CHE · Chemed Corp · Webcasts, Transcripts & Audio
$546.85
+0.13 (+0.02%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.12B
Shares
13.01M
Volume · Nov 19
24.83K
Avg daily vol (3M)
151.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Chemed Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Chemed Corp (CHE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-09
Chemed Corp (CHE) November 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-28
Chemed Corp (CHE) Q3 2026 Earnings Call Transcript
Confident tone
Roto-Rooter marketing and lead-generation costs
VITAS growth and strong financial performance
Roto-Rooter organic growth and margin recovery
Revenue
$690.94M
▲ 10.6% YoY Diluted EPS
$5.45
▲ 22.2% YoY Gross margin
33.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-15
Chemed Corp (CHE) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-29
Chemed Corp (CHE) Q2 2026 Earnings Call Transcript
Confident tone
VITAS hospice admissions growth
Florida Medicare cap position
Roto-Rooter commercial business
Revenue
$673.25M
▲ 8.8% YoY Diluted EPS
$5.13
▲ 43.7% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-05-20
Chemed Corp (CHE) May 20, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Chemed Corp (CHE) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-24
Chemed Corp (CHE) Q1 2026 Earnings Call Transcript
Confident tone
VITAS admissions and patient mix
VITAS regulatory and fraud concerns
Florida Medicare cap position
Revenue
$657.51M
▲ 1.6% YoY Diluted EPS
$4.84
▼ 0.4% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Chemed Corp (CHE) Q4 2025 Earnings Call Transcript
Positive tone
Paid vs. natural search leads
VITAS admissions mix rebalancing
Water restoration billing and collections
Revenue
$639.34M*
▼ 0.1% YoY Gross margin
34.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Chemed Corp (CHE) Q3 2025 Earnings Call Transcript
Positive tone
VITAS Medicare Cap mitigation
Lead generation mix shift
VITAS admissions and census growth
Revenue
$624.90M
▲ 3.1% YoY Diluted EPS
$4.46
▼ 10.8% YoY Gross margin
32.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Chemed Corp (CHE) Q2 2025 Earnings Call Transcript
Cautious tone
VITAS Medicare cap / Florida billing limitation
VITAS admissions and patient mix
Roto-Rooter competition and marketing
Revenue
$618.80M
▲ 3.8% YoY Diluted EPS
$3.57
▼ 23.2% YoY Gross margin
29.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Chemed Corp (CHE) Q1 2025 Earnings Call Transcript
Confident tone
VITAS operating performance and growth
Roto Rooter revenue and margin trends
Medicare cap management
Revenue
$646.94M
▲ 9.8% YoY Diluted EPS
$4.86
▲ 14.6% YoY Gross margin
33.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Chemed Corp (CHE) Q4 2024 Earnings Call Transcript
Positive tone
VITAS Healthcare operations
2025 financial guidance
Medicare cap limitations
Revenue
$639.99M*
▲ 9.2% YoY Gross margin
36.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Chemed Corp (CHE) Q3 2024 Earnings Call Transcript
Balanced tone
Roto-Rooter revenue decline
VITAS Healthcare strong performance
2025 outlook and guidance
Revenue
$606.18M
▲ 7.4% YoY Diluted EPS
$5.00
▲ 1.4% YoY Gross margin
34.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Chemed Corp (CHE) Q2 2024 Earnings Call Transcript
Confident tone
Covenant Health Acquisition
VITAS Hospice Operating Strength
Florida Market Expansion (CON)
Revenue
$595.88M
▲ 7.6% YoY Diluted EPS
$4.65
▲ 32.5% YoY Gross margin
34.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript
Positive tone
VITAS admissions and census growth
VITAS hiring and retention
Covenant Health and Community Services acquisition
Revenue
$589.23M
▲ 5.2% YoY Diluted EPS
$4.24
▲ 18.4% YoY Gross margin
34.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Chemed Corp (CHE) Q4 2023 Earnings Call Transcript
Positive tone
2024 guidance and margin outlook
VITAS operational improvement and ADC growth
Medicare reimbursement dynamics
Revenue
$585.91M*
▲ 7.2% YoY Gross margin
38.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Chemed Corp (CHE) Q3 2023 Earnings Call Transcript
Revenue
$564.53M
▲ 7.2% YoY Diluted EPS
$4.93
▲ 30.4% YoY Gross margin
35.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Chemed Corp (CHE) Q2 2023 Earnings Call Transcript
Revenue
$553.82M
▲ 4.2% YoY Diluted EPS
$3.51
▼ 20.2% YoY Gross margin
32.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Chemed Corp (CHE) Q1 2023 Earnings Call Transcript
Revenue
$560.16M
▲ 5.6% YoY Diluted EPS
$3.58
▼ 15.2% YoY Gross margin
33.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Chemed Corp (CHE) Q4 2022 Earnings Call Transcript
Revenue
$546.65M*
▲ 1% YoY Gross margin
36.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-31
Chemed Corp (CHE) Q3 2022 Earnings Call Transcript
Revenue
$526.47M
▼ 2.3% YoY Diluted EPS
$3.78
▼ 16.9% YoY Gross margin
34.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Chemed Corp (CHE) Q2 2022 Earnings Call Transcript
Revenue
$531.29M
▼ 0.2% YoY Diluted EPS
$4.40
▲ 25.4% YoY Gross margin
36.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-26
Chemed Corp (CHE) Q1 2022 Earnings Call Transcript
Revenue
$530.55M
▲ 0.6% YoY Diluted EPS
$4.22
▲ 5.2% YoY Gross margin
36.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Chemed Corp (CHE) Q4 2021 Earnings Call Transcript
Revenue
$540.98M*
▲ 1.4% YoY Gross margin
37.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Chemed Corp (CHE) Q3 2021 Earnings Call Transcript
Revenue
$538.67M
▲ 2% YoY Diluted EPS
$4.55
▲ 9.9% YoY Gross margin
36.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Chemed Corp (CHE) Q2 2021 Earnings Call Transcript
Revenue
$532.26M
▲ 6% YoY Diluted EPS
$3.51
▼ 29.9% YoY Gross margin
34.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
Chemed Corp (CHE) Q1 2021 Earnings Call Transcript
Revenue
$527.36M
▲ 2.2% YoY Diluted EPS
$4.01
▲ 18.6% YoY Gross margin
35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Chemed Corp (CHE) Q4 2020 Earnings Call Transcript
Revenue
$533.29M*
▲ 2.1% YoY Gross margin
37.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Chemed Corp (CHE) Q3 2020 Earnings Call Transcript
Revenue
$528.30M
▲ 9.9% YoY Diluted EPS
$4.14
▲ 16.3% YoY Gross margin
35.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Chemed Corp (CHE) Q2 2020 Earnings Call Transcript
Revenue
$502.20M
▲ 6% YoY Diluted EPS
$5.01
▲ 62.7% YoY Gross margin
29.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Chemed Corp (CHE) Q1 2020 Earnings Call Transcript
Revenue
$515.80M
▲ 11.6% YoY Diluted EPS
$3.38
▲ 25.2% YoY Gross margin
31.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-18
Chemed Corp (CHE) Q4 2019 Earnings Call
Revenue
$522.32M*
▲ 14.2% YoY Gross margin
33.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–32 of 32 webcasts
Key facts
CIK
19584
CUSIP
16359R103
13F (30d)
559 filings
500 filers
Visit website
Investor relations